Mass Production Process of "Microencapsulation": How to Keep Active Ingredients Stable and Alive for 12 Months?
Updated: Sep 17
Have you ever encountered this dilemma: The formula clearly contains a high concentration of Vitamin C, but the product starts to yellow and develop an off-odor just 3 months after leaving the factory; the Retinol content is sufficient, yet it degrades rapidly during its shelf life, leaving consumers unable to feel the claimed anti-aging effects after finishing a bottle; or ingredients like plant polyphenols and niacinamide react with other raw materials, leading to formulation instability and inconsistent batch-to-batch quality.
The root cause of these issues is not that the ingredients themselves are ineffective, but that they simply cannot "survive" 12 months in traditional formulation systems.
Microencapsulation technology is currently the most systematic and mature industrial solution in the cosmetics industry to solve this problem. However, how to move this technology from the laboratory to the mass production workshop—stably, efficiently, and reproducibly at scale—is the true watershed that separates the core competitiveness of OEM/ODM factories.
I. Why Are Active Ingredients So Hard to "Keep Alive"?
Before explaining microencapsulation, we must first understand the essence of the problem.
Many common bioactive ingredients in cosmetics—including retinol, ascorbic acid (Vitamin C), tocopherol (Vitamin E), catechins, caffeine, rosmarinic acid, resveratrol, linoleic acid, and lycopene—are highly susceptible to degradation by environmental factors such as heat, light, and oxidation. The instability of these ingredients is one of the core formulation challenges facing the cosmetics industry.
Let's look at two of the most representative ingredients:
Vitamin C (L-Ascorbic Acid): Highly prone to oxidation in aqueous solutions. Contact with metal ions (copper, iron) accelerates degradation, and it rapidly inactivates at higher pH levels. Unprotected Vitamin C serums can lose over 60% of their active ingredients within weeks of opening. Comparative test data shows that unencapsulated free ascorbic acid solutions stored at 40°C for 6 months retain less than 40% of their active ingredients.
Retinol: Decomposes upon light exposure, oxidizes and loses efficacy in air, is highly irritating, and has poor compatibility with other ingredients. This is precisely why microencapsulated retinol has become a breakthrough innovation in the industry. By encapsulating retinol molecules within microcapsules, their contact with external factors like light, oxygen, and heat is effectively blocked, maintaining the ingredient's integrity both inside the packaging and until it is applied to the skin.
This is not just a data game in the laboratory; it is a core issue that directly determines whether consumers can truly experience the product's efficacy and whether brands can deliver on their claims.
II. The Underlying Logic of Microencapsulation: Building a "Bulletproof House" for Active Ingredients
The core principle of microencapsulation technology can be understood through an intuitive analogy:
Enclosing an active ingredient (Core Material) within a shell (Wall Material) made of polymers, lipids, or proteins, forming microcapsules typically ranging from 1 to 1000 micrometers in diameter. This shell isolates oxygen, moisture, light, and other formulation ingredients that might react with the core. Simultaneously, it enables precise release at the target site through specific trigger mechanisms, such as pressure, pH changes, body temperature, or time.
Microencapsulation provides an ideal and unique carrier system for cosmetic active ingredients, simultaneously meeting multiple needs: enhancing the stability of active substances, achieving controlled transdermal release, and protecting ingredient activity during formulation preparation and storage.
Market demand for this technology is growing rapidly. According to industry research data, the global microencapsulation market reached $15.63 billion in 2025, is projected to grow to $17.29 billion in 2026, and will continue to expand at a CAGR of 10.68% to reach $38.96 billion by 2034. Home and personal care products account for approximately 18% of the overall market share, making it one of the core application areas driving this growth.
III. Detailed Explanation of the Three Mainstream Mass Production Processes
Understanding the principle leads to the practical question brand owners care about most: How is this technology mass-produced, and which process suits my product?
Process 1: Spray Drying — The Most Mature Industrial Path
Spray drying is one of the most widely used processes for microencapsulation mass production in the cosmetics industry. The basic flow involves mixing the active ingredient with a wall material solution to form a uniform emulsion or suspension, which is then atomized through a high-pressure atomizer into a hot air drying tower. The droplets instantly evaporate their moisture, forming fully encapsulated microcapsule powders.
A systematic review published in June 2025 indicates that spray drying microencapsulation technology can achieve high encapsulation efficiency by selecting different wall materials, significantly improving the stability of bioactive substances, and effectively controlling the release rate. Various compounds, including polyphenols, essential oils, carotenoids, fatty acids, and vitamins, have been successfully microencapsulated using this technology, showing significant protective effects against oxidation, light, and temperature.
Mass Production Advantages: Mature equipment, high capacity, continuous production, and relatively controllable costs. It is the preferred process for powdered microcapsule products.
Main Challenges: Inlet temperatures typically need to be controlled between 150°C and 220°C. For highly heat-sensitive ingredients, cold treatment modifications or alternative paths must be selected.
Process 2: Liposome Encapsulation — Strongest Skin Affinity
Liposomes are spherical vesicles composed of phospholipid bilayers. Their structure is highly similar to skin cell membranes, giving them natural skin affinity and transdermal penetration advantages. Water-soluble ingredients are encapsulated in the aqueous core, while lipid-soluble ingredients are embedded within the phospholipid layer, enabling the simultaneous loading of amphiphilic ingredients.
For ingredients like retinol, Vitamin C, or peptides, liposome encapsulation is considered the most well-documented solution for stability and transdermal delivery in scientific literature. Comparative studies have confirmed that under identical storage conditions, the oxidation rate of liposome-encapsulated retinol is significantly lower than that of free retinol, and this effective reduction in degradation rate directly translates to an extended product shelf life.
On the mass production side, the application of microfluidization technology has made the large-scale preparation of liposomes a reality, ensuring batch-to-batch consistency through fixed-geometry interaction chambers.
Mass Production Advantages: High encapsulation efficiency, excellent skin compatibility, suitable for high-end efficacy product claims, and capable of simultaneously encapsulating both water- and lipid-soluble ingredients.
Main Challenges: High production process requirements, higher batch costs than spray drying; requires particle size testing (Dynamic Light Scattering, DLS) to ensure batch stability.
Process 3: Polymer Microcapsule — Most Flexible Release Control
Polymer microcapsules use natural or synthetic polymers (e.g., sodium alginate, ethyl cellulose, PMMA) as wall materials, constructing the encapsulation structure through interfacial polymerization, solvent evaporation, or phase separation. Due to their excellent thermochemical stability, low toxicity, and good elastic mechanical properties, polymer materials are widely adopted in microcapsule wall applications.
By adjusting the polymer's molecular weight, cross-linking degree, and membrane thickness, the release rate of the active ingredient can be precisely controlled—ranging from "burst release" upon skin friction to "sustained release" over 8 to 12 hours, with the release curve customizable to formulation needs.
Mass Production Advantages: Strongest tunability of the release mechanism, good structural stability, suitable for diverse scenarios such as fragrance microcapsules (burst beads), sunscreen ingredients, and nighttime repair sustained-release formulas.
Main Challenges: The environmental compliance of wall materials must be evaluated. Especially with the tightening of the EU Microplastics Regulation, biodegradable alternative wall materials must be selected to replace synthetic polymer particles.
IV. From Lab to Mass Production: 5 Most Easily Overlooked Key Parameters
When communicating with contract manufacturers about microencapsulation processes, brand owners often focus only on "can it be done," while overlooking the key process parameters that determine mass production success. Here are 5 core control points summarized from experience:
① Encapsulation Efficiency (EE)
Encapsulation efficiency measures the ratio of the active ingredient actually encapsulated within the microcapsules to the total input amount. Advanced pan coating processes can achieve an EE of over 90% while producing microcapsules with uniform particle sizes. Contract manufacturers must be able to provide EE test reports for every batch, not just theoretical values.
② Particle Size & Particle Size Distribution (PSD)
Microcapsule particle size directly affects the product's skin feel (too large causes a gritty sensation), stability, and release speed. Mass production requires the PSD (D50, D90 values) of each batch to fall within specification ranges, typically tested via laser diffraction or Dynamic Light Scattering (DLS). Batch-to-batch D50 deviation should be controlled within ±15%.
③ Stability Data
Claims of "12-month stability" must be backed by data, not verbal promises. Standard stability testing includes: long-term stability testing at 25°C/60% RH (simulating normal shelf life) and accelerated stability testing at 40°C/75% RH (6 months of acceleration simulating 36 months of actual shelf life). A reliable contract manufacturer must be able to provide both accelerated and real-time stability data for every batch of microencapsulated products. This is the only credible way to verify the claim that "active ingredients survive for 12 months."
④ Wall Material Compliance
For products targeting European and American markets, the regulatory compliance of wall material ingredients is crucial. Starch derivatives and cellulose-based polymer wall materials comply with the US MoCRA (Modernization of Cosmetics Regulation Act) and the EU Microplastics Regulation. They can achieve long-term stability without relying on PEG, silicones, or microplastic additives, aligning perfectly with the demands of sustainable, eco-certified cosmetic formulations.
⑤ Batch-to-Batch Consistency
Microencapsulation processes are highly sensitive to parameter fluctuations. Contract manufacturers must possess validated scale-up SOPs to ensure process parameter consistency from a 10L pilot tank to a 1000L mass production tank. Key variables, including homogenization pressure, temperature curves, and nozzle flow rates, must all be managed under Statistical Process Control (SPC).
V. Technology Trends: Three New Directions in the 2026 Microencapsulation Market
The industry is always moving forward. Understanding the latest trends helps brand owners make more forward-looking technical choices during product development.
① Ingredient Microencapsulation Innovation Led by Major Brands
In January 2025, BASF Personal Care launched VitaGuard A, a microencapsulated retinol raw material specifically developed for anti-aging products. Its encapsulation technology significantly reduces skin irritation compared to traditional formulas while enhancing stability, balancing efficacy and gentleness. This trend indicates that microencapsulation technology has evolved from an "optional extra" to a "standard feature" for high-end efficacy products.
② Rapid Growth in Demand for Microencapsulated Peptides and Vitamin C
Market data shows that the cosmetic microsphere encapsulation market reached $1.7523 billion in 2025, with the combined growth of peptides, Vitamin C, and UV filters accounting for over 40% of this expansion, making them the core categories driving industry growth. This trend directly reflects the market's strong demand for "stable, high-efficacy ingredients."
③ Biodegradable Wall Materials Becoming the New Standard
Driven by the advancement of the EU Microplastics Regulation and the deepening global Clean Beauty wave, traditional synthetic polymer wall materials are being rapidly replaced by plant-derived natural wall materials (such as zein, maltodextrin, and plant proteins). Recent review studies indicate that using innovative wall materials like plant proteins for spray-drying microencapsulation not only successfully protects various sensitive active substances but also provides greater space for the future development of personalized formulations and stimuli-responsive release systems.
Scaling up should not mean re-learning the formula.
The most expensive stage of a launch is usually the second trial — the one where a bench formula meets the filling line and the numbers move. We engineer for the line, not the beaker.
Packaging compatibility, stability and fill accuracy are validated before commercial scale rather than discovered during it.
By collaborating with Explore our skincare manufacturing capabilities you gain access to industry-leading expertise and innovative formulations that set your brand apart in the competitive global market. Share your target output and packaging format; we will confirm line feasibility before you commit.
Comments